We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Bladder Cancer

Journal Scan / Research · November 22, 2022

Nab-Paclitaxel in Combination With Anti–PD-1 Therapy in Advanced Urothelial Cancer

The Journal of Urology


Additional Info

The Journal of Urology
A Phase 2 Trial of Nab-paclitaxel in Combination With Anti-PD1 Therapy in Advanced Urothelial Cancer
J Urol 2022 Nov 01;[EPub Ahead of Print], I Tsung, E Green, P Palmbos, Z Sloan, ZR Reichert, U Vaishampayan, DC Smith, MEV Caram, S Yentz, S Daignault-Newton, L Hurley, CB Nguyen, S Kraft, A Alva

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading